Your HRV Is Low, Your Genes May Be Why.

Nitric oxide is your blood vessels’ master regulator. It signals your arterial walls to relax and dilate, allowing blood to flow freely. This matters enormously for HRV because good heart rate variability depends on your blood vessels’ ability to adjust their diameter in response to your nervous system’s signals. When your parasympathetic nervous system fires, nitric oxide production should increase, vessels should dilate, and your HRV should improve. NOS3 is the enzyme that produces this critical molecule.

The NOS3 Glu298Asp variant, carried by roughly 30-40% of the population, reduces the enzyme’s ability to produce nitric oxide in response to shear stress and endothelial stimulation. People with this variant experience chronically lower nitric oxide availability, which means their blood vessels are less responsive to nervous system signals and their HRV never reaches its potential. This isn’t a minor effect. It’s a structural limit on how much your cardiovascular system can adapt.

You feel this as a persistent ceiling on your HRV. You can train your parasympathetic tone, but your vessels don’t dilate as efficiently as they should. Your resting heart rate doesn’t drop as low during deep relaxation. During intense exercise, your arteries can’t expand enough to match the demand, so cardiac output stays constrained. Recovery after hard training is slower because the vasodilatory signal that should tell your body it’s safe to relax is muted.

The angiotensin system is your body’s ancient blood pressure controller. When blood pressure drops, your kidneys release a hormone cascade that tightens your blood vessels and raises pressure back up. This is essential for survival. But like any powerful system, it can be overactive. ACE is the enzyme that converts angiotensin I into angiotensin II, the potent vasoconstrictor. How much ACE you produce is partly genetic.

The ACE I/D polymorphism determines how much enzyme your cells make. People with the D/D genotype, representing roughly 25% of the population, have higher baseline ACE activity and produce more angiotensin II. This means your arteries are more prone to constriction, your blood pressure runs higher at baseline, and your heart has to work harder to maintain adequate flow, which suppresses HRV. The constant low-level sympathetic tone from hypertension is incompatible with good heart rate variability.

You experience this as a resting heart rate that’s higher than it should be, poor HRV recovery after stress, and a cardiovascular system that feels reactive. Your blood vessels are biologically biased toward constriction. Even when you relax, the sympathetic dominance doesn’t fully release because your baseline angiotensin II is keeping your vessels tense. Your HRV ceiling is lower than someone with the I/I genotype who produces less ACE.

MTHFR catalyzes a critical step in the methylation cycle, the biochemical highway that produces the methyl groups needed for hundreds of cellular processes. One of those processes is converting homocysteine, a toxic amino acid byproduct, into methionine. When MTHFR works well, homocysteine gets cleared efficiently. When it doesn’t, homocysteine accumulates.

The MTHFR C677T variant, present in roughly 40% of the population, reduces enzyme efficiency by 40-70%. People with this variant accumulate homocysteine, and elevated homocysteine is an independent cardiovascular risk factor that damages blood vessel walls, promotes inflammation, and increases clotting risk, all of which suppress HRV. Your cardiovascular system is essentially running in a pro-inflammatory, pro-thrombotic state.

You feel this as persistent low HRV even when you’re relaxed, a sense that your cardiovascular system is always slightly inflamed, and poor recovery from training. Your heart has to work harder to maintain adequate perfusion through vessels that are under chronic oxidative stress. Blood clotting risk is elevated, which keeps your autonomic nervous system vigilant (another HRV suppressor). Your parasympathetic nervous system can’t fully engage because your body’s inflammatory baseline is too high.

COMT breaks down dopamine, norepinephrine, and epinephrine. These are your stress hormones and motivation neurotransmitters. When COMT works well, it clears these hormones after a stressor passes, allowing your nervous system to downshift. When COMT is slow, stress hormones linger, keeping you in sympathetic overdrive. HRV is the direct result of your parasympathetic nervous system’s ability to downregulate your heart. If stress hormones are chronically elevated, your parasympathetic tone can’t overcome them.

The COMT Val158Met variant determines whether you’re a fast or slow COMT metabolizer. People homozygous for the Met allele, representing roughly 25% of European ancestry, are slow metabolizers. Slow COMT carriers experience prolonged elevation of stress hormones after even mild stressors, which means their sympathetic nervous system stays activated longer, their HRV stays depressed, and their baseline heart rate stays elevated. They can’t shake the stress response.

You experience this as a nervous system that won’t downshift. You finish a stressful meeting and your heart rate takes 30 minutes to recover when it should take 5. Your HRV dips dramatically on moderately stressful days and never fully rebounds. You’re sensitive to caffeine and stimulants because they amplify stress hormone accumulation. Even at rest, your resting heart rate is higher than it should be because your baseline norepinephrine is elevated.

SCN5A encodes the primary sodium channel in the heart’s ventricles. Every heartbeat is triggered by electrical signals that flow through the heart in a precise choreography. Sodium ions flow through these channels, depolarizing the heart cells and triggering contraction. The speed and voltage of this signal determine your heart’s rhythm. Variants in SCN5A can slow conduction or make the channels less responsive, altering the heart’s electrical behavior.

SCN5A variants vary widely in their severity and effect. Some people carry variants that cause obvious arrhythmias; others have subclinical effects that show up only as low HRV, subtle electrical delays, or poor adaptation during stress. When SCN5A function is reduced, the heart’s electrical rhythm becomes less flexible, meaning it can’t speed up and slow down as fluidly in response to breathing and parasympathetic tone, and HRV decreases. The heart is electrically rigid.

You feel this as an HRV that doesn’t respond well to training interventions, an irregular feeling in your chest (not necessarily a diagnosed arrhythmia), or a sensation that your heart is working harder to maintain its rhythm than it should. Your heart rate variability is particularly poor during exercise recovery because the heart’s electrical system can’t quickly shift from sympathetic to parasympathetic tone. Stress, caffeine, or electrolyte imbalances can trigger palpitations or an off-beat feeling.

KCNQ1 encodes a potassium channel in the heart that helps repolarize the heart cells after they’ve fired. Think of it as the reset button after each heartbeat. Potassium ions flow out through these channels, bringing the electrical voltage back down to baseline so the next beat can fire. This repolarization phase is crucial for HRV because the variability in the timing between beats depends on how flexibly the heart can adjust its electrical cycle.

KCNQ1 variants can slow repolarization or reduce channel function. When KCNQ1 function is impaired, the heart’s recovery between beats becomes less responsive to parasympathetic signals, meaning your HRV becomes artificially constrained and your heart rate can’t adapt as dynamically to breathing or stress states. The heart is electrically sluggish.

You experience this as low HRV that stubbornly resists training and breathing interventions. Your heart rate doesn’t speed up and slow down smoothly with your breath. During exercise, your heart rate climbs too quickly and doesn’t drop quickly enough afterward. Your cardiac recovery is poor. You may notice your HRV is particularly low in the morning or after a night of poor sleep, because that’s when parasympathetic tone is lowest and the heart needs maximum electrical flexibility to respond.